tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Technical Analysis

Compare
4,764 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -0.32, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 142.32, while Biogen’s (BIIB) share price is $140.9, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 144.86, while Biogen’s (BIIB) share price is $140.9, making it a Sell.

Biogen (BIIB) Pivot Points

Mar 25, 2025, 07:32 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
138.50
139.71
140.54
141.75
142.58
143.79
144.62
Fibonacci
139.71
140.49
140.97
141.75
142.53
143.01
143.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Mar 25, 2025, 07:32 AM
Period
Simple
Exponential
MA5
142.07Sell
141.58Sell
MA10
142.43Sell
142.09Sell
MA20
142.79Sell
142.32Sell
MA50
142.60Sell
144.86Sell
MA100
151.66Sell
154.19Sell
MA200
180.17Sell
176.12Sell
Biogen’s (BIIB) 10-Day exponential moving average is 142.09, while Biogen’s (BIIB) share price is $140.9, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 154.19, while Biogen’s (BIIB) share price is $140.9, making it a Sell.
Biogen’s (BIIB) stock price is $140.9 and Biogen’s (BIIB) 50-day simple moving average is 142.60, creating a Sell signal.
Biogen’s (BIIB) stock price is $140.9 and Biogen’s (BIIB) 100-day simple moving average is 151.66, creating a Sell signal.
Biogen’s (BIIB) stock price is $140.9 and Biogen’s (BIIB) 200-day simple moving average is 180.17, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Mar 25, 2025, 07:32 AM
Name
Value
Implied Action
RSI (14)
46.43
Neutral
STOCH (9,6)
15.73
Buy
STOCHRSI (14)
14.50
Buy
MACD (12,26)
-0.32
Buy
ADX (14)
16.04
Buy
Williams %R
-87.70
Buy
CCI (14)
-59.46
Neutral
ATR (14)
4.18
-
Ultimate Oscillator
37.73
Neutral
ROC
-0.57
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 46.43, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 16.04, creating a Buy signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -59.46, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -0.57, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 46.43, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is -0.32, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 142.07, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 142.79, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 142.60, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 180.17, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -87.70, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -59.46, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis